Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Despite contributing to the majority of ambient fine particle (PM2.5), PM1 (particulate matter [PM] with aerodynamic diameter ≤1 μm) remains poorly studied in terms of its acute effects on cardiovascular diseases (CVDs) in China. This study aims to evaluate the short-term associations of PM1, PM2.5, and PM10 exposures with hospital admissions for CVDs in a southern Chinese metropolis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We collected 5969 records of hospital admissions for CVDs and daily average concentrations of air pollutants and weather conditions in Shenzhen from January 1st 2015 to December 31st 2017. We adopted a time-stratified case-crossover design and conditional logistic regression models to assess short-term associations between size-specific PMs (i.e., PM1, PM2.5, and PM10) and CVD hospitalizations along different exposure days.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>During the study period, annual average concentrations of PM1, PM2.5, and PM10 were 18.7, 27.8, and 45.4 μg/m3, respectively. Compared to PM2.5 and PM10, PM1 exhibited a generally stronger association with CVD hospitalizations. Hospital admissions for CVDs increased by 6.7% (95% confidence interval: 1.2–12.5%), 4.5% (0.4–8.7%), and 3.4% (0.5–6.3%), corresponding to per 10-μg/m3 rise in exposure to PM1, PM2.5, and PM10 at lag 03 days. In our stratified analyses by CVD sub-causes, size-specific PMs showed consistent effects on hypertension but no evident association with ischemic heart disease (IHD) and stroke. Seasonal analysis revealed significantly larger PM-associated risks among IHD patients in cold months (October–March). Nevertheless, in warm months (April–September), the older group (aged 65+ years) was more prone to the adverse effect of PM1 exposure at lag 0 day.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Short-term exposure to size-specific PMs, PM1 in particular, may trigger the incidence of CVD hospitalization. To effectively mitigate the adverse effects of particulate pollution, evidence-based PM1 standards should be developed as well in Chinese less-polluted megacities.</p>

Size-specific particulate air pollution and hospitalization for cardiovascular diseases: A case-crossover study in Shenzhen, China